Sold as Diabinese. Every FDA application for this active ingredient: 1 branded and 32 generic.
As of Nov 13, 2026, FDA lists 33 applications for Chlorpropamide (sold as Diabinese), first approved Oct 28, 1958, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Oct 28, 1958 | DiabineseNDA 11641 · New molecular entity | Pfizer | 19 | Discontinued |
| Jul 10, 1980 | ChlorpropamideANDA 84669 | Sandoz | 1 | Discontinued |
| Jun 26, 1981 | ChlorpropamideANDA 87353 | Ani Pharms | 0 | Discontinued |
| Feb 27, 1984 | ChlorpropamideANDA 88176 | Par Pharm | 10 | Discontinued |
| Feb 27, 1984 | ChlorpropamideANDA 88175 | Par Pharm | 9 | Discontinued |
| Jun 1, 1984 | ChlorpropamideANDA 88549 | Pharmobedient | 10 | Discontinued |
| Aug 31, 1984 | ChlorpropamideANDA 88725 | Rising | 9 | Discontinued |
| Aug 31, 1984 | ChlorpropamideANDA 88726 | Rising | 7 | Discontinued |
| Sep 17, 1984 | ChlorpropamideANDA 88695 | Superpharm | 1 | Discontinued |
| Sep 24, 1984 | ChlorpropamideANDA 86865 | Watson Labs | 0 | Discontinued |
| Sep 26, 1984 | ChlorpropamideANDA 88852 | Watson Labs Teva | 11 | Discontinued |
| Sep 26, 1984 | ChlorpropamideANDA 88826 | Ani Pharms | 12 | Discontinued |
| Oct 11, 1984 | GlucamideANDA 88641 | Ani Pharms | 0 | Discontinued |
| Oct 11, 1984 | ChlorpropamideANDA 88768 | Ani Pharms | 0 | Discontinued |
| Oct 16, 1984 | ChlorpropamideANDA 88918 | Ani Pharms | 1 | Discontinued |
| Oct 16, 1984 | ChlorpropamideANDA 88919 | Ani Pharms | 1 | Discontinued |
| Oct 19, 1984 | ChlorpropamideANDA 88812 | Ani Pharms | 3 | Discontinued |
| Oct 19, 1984 | ChlorpropamideANDA 88813 | Ani Pharms | 3 | Discontinued |
| Oct 25, 1984 | ChlorpropamideANDA 88840 | Ani Pharms | 0 | Discontinued |
| Apr 12, 1985 | ChlorpropamideANDA 88921 | Ani Pharms | 14 | Discontinued |
| Apr 12, 1985 | ChlorpropamideANDA 88922 | Ani Pharms | 15 | Discontinued |
| Nov 17, 1986 | ChlorpropamideANDA 89446 | Ani Pharms | 3 | Discontinued |
| Nov 17, 1986 | ChlorpropamideANDA 89447 | Ani Pharms | 3 | Discontinued |
| — | ChlorpropamideANDA 88568 | Watson Labs | 0 | Discontinued |
| — | ChlorpropamideANDA 88608 | Watson Labs | 0 | Discontinued |
| — | ChlorpropamideANDA 88662 | Halsey | 0 | Discontinued |
| — | ChlorpropamideANDA 88694 | Superpharm | 0 | Discontinued |
| — | ChlorpropamideANDA 88708 | Usl Pharma | 0 | Discontinued |
| — | ChlorpropamideANDA 88709 | Usl Pharma | 0 | Discontinued |
| — | ChlorpropamideANDA 89321 | Halsey | 0 | Discontinued |
| — | ChlorpropamideANDA 89561 | Dava Pharms Inc | 0 | Discontinued |
| — | ChlorpropamideANDA 89562 | Dava Pharms Inc | 0 | Discontinued |
| — | ChlorpropamideANDA 86866 | Watson Labs | 6 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Pfizer
Sandoz